Form 10-K - Annual report [Section 13 and 15(d), not S-K Item 405]:
SEC Accession No. 0001558370-25-000953
Filing Date
2025-02-13
Accepted
2025-02-13 17:09:26
Documents
155
Period of Report
2024-12-31

Document Format Files

Seq Description Document Type Size
1 10-K bpmc-20241231x10k.htm   iXBRL 10-K 3883814
2 EX-21.1 bpmc-20241231xex21d1.htm EX-21.1 6871
3 EX-23.1 bpmc-20241231xex23d1.htm EX-23.1 7151
4 EX-31.1 bpmc-20241231xex31d1.htm EX-31.1 11665
5 EX-31.2 bpmc-20241231xex31d2.htm EX-31.2 11907
6 EX-32.1 bpmc-20241231xex32d1.htm EX-32.1 10060
7 GRAPHIC bpmc-20241231x10k006.jpg GRAPHIC 154957
8 GRAPHIC bpmc-20241231x10k007.jpg GRAPHIC 88858
  Complete submission text file 0001558370-25-000953.txt   16935017

Data Files

Seq Description Document Type Size
9 EX-101.SCH bpmc-20241231.xsd EX-101.SCH 121936
10 EX-101.CAL bpmc-20241231_cal.xml EX-101.CAL 116559
11 EX-101.DEF bpmc-20241231_def.xml EX-101.DEF 479593
12 EX-101.LAB bpmc-20241231_lab.xml EX-101.LAB 934578
13 EX-101.PRE bpmc-20241231_pre.xml EX-101.PRE 849483
158 EXTRACTED XBRL INSTANCE DOCUMENT bpmc-20241231x10k_htm.xml XML 2954418
Mailing Address 45 SIDNEY STREET CAMBRIDGE MA 02139
Business Address 45 SIDNEY STREET CAMBRIDGE MA 02139 617-374-7580
Blueprint Medicines Corp (Filer) CIK: 0001597264 (see all company filings)

EIN.: 000000000 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 10-K | Act: 34 | File No.: 001-37359 | Film No.: 25621502
SIC: 2834 Pharmaceutical Preparations
(CF Office: 03 Life Sciences)